These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
516 related articles for article (PubMed ID: 16207644)
1. Label claims for foods and supplements: a review of the regulations. Turner RE; Degnan FH; Archer DL Nutr Clin Pract; 2005 Feb; 20(1):21-32. PubMed ID: 16207644 [TBL] [Abstract][Full Text] [Related]
2. Health claims in the United States: an aid to the public or a source of confusion? Hasler CM J Nutr; 2008 Jun; 138(6):1216S-20S. PubMed ID: 18492860 [TBL] [Abstract][Full Text] [Related]
3. US Food and Drug Administration regulations governing label claims for food products, including probiotics. Saldanha LG Clin Infect Dis; 2008 Feb; 46 Suppl 2():S119-21; discussion S144-51. PubMed ID: 18181715 [TBL] [Abstract][Full Text] [Related]
5. How the US Food and Drug Administration evaluates the scientific evidence for health claims. Ellwood KC; Trumbo PR; Kavanaugh CJ Nutr Rev; 2010 Feb; 68(2):114-21. PubMed ID: 20137056 [TBL] [Abstract][Full Text] [Related]
9. Consumer perceptions of graded, graphic and text label presentations for qualified health claims. Kapsak WR; Schmidt D; Childs NM; Meunier J; White C Crit Rev Food Sci Nutr; 2008 Mar; 48(3):248-56. PubMed ID: 18274974 [TBL] [Abstract][Full Text] [Related]
10. [Health Council report on health claims for foods and food supplements]. Gerritsen WJ Ned Tijdschr Geneeskd; 2003 Oct; 147(42):2048-50. PubMed ID: 14606350 [TBL] [Abstract][Full Text] [Related]
12. Weight of evidence needed to substantiate a health effect for probiotics and prebiotics: regulatory considerations in Canada, E.U., and U.S. Sanders ME; Tompkins T; Heimbach JT; Kolida S Eur J Nutr; 2005 Aug; 44(5):303-10. PubMed ID: 15338247 [TBL] [Abstract][Full Text] [Related]
13. Functional foods: the Food and Drug Administration perspective. Ross S Am J Clin Nutr; 2000 Jun; 71(6 Suppl):1735S-8S; discussion 1739S-42S. PubMed ID: 10837331 [TBL] [Abstract][Full Text] [Related]
14. Evidence for health claims: a perspective from the Australia-New Zealand region. Tapsell LC J Nutr; 2008 Jun; 138(6):1206S-9S. PubMed ID: 18492858 [TBL] [Abstract][Full Text] [Related]
15. Dietary supplements: how they are used and regulated. Hathcock J J Nutr; 2001 Mar; 131(3s):1114S-7S. PubMed ID: 11238828 [TBL] [Abstract][Full Text] [Related]
17. Dissecting qualified health claims: evidence from experimental studies. Hooker NH; Teratanavat R Crit Rev Food Sci Nutr; 2008 Feb; 48(2):160-76. PubMed ID: 18274970 [TBL] [Abstract][Full Text] [Related]
18. FDA perspectives on health claims for food labels. Rowlands JC; Hoadley JE Toxicology; 2006 Apr; 221(1):35-43. PubMed ID: 16480811 [TBL] [Abstract][Full Text] [Related]
19. Structure/function claims in dietary supplement labeling: not all of these claims need to be submitted to FDA and accompanied in labeling by the DSHEA disclaimer. McNamara SH Food Drug Law J; 1999; 54(1):35-42. PubMed ID: 11758558 [No Abstract] [Full Text] [Related]
20. Regulations on statements made for dietary supplements concerning the effect of the product on the structure or function of the body. Food and Drug Administration, HHS. Final rule. Fed Regist; 2000 Jan; 65(4):1000-50. PubMed ID: 11010621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]